Literature DB >> 26382951

Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China.

Mao-Sheng Ran1, Xue Weng2, Cecilia Lai-Wan Chan2, Eric Yu-Hai Chen2, Cui-Ping Tang2, Fu-Rong Lin2, Wen-Jun Mao2, Shi-Hui Hu2, Yue-Qin Huang2, Meng-Ze Xiang2.   

Abstract

BACKGROUND: The long-term outcome of never-treated patients with schizophrenia is unclear. AIMS: To compare the 14-year outcomes of never-treated and treated patients with schizophrenia and to establish predictors for never being treated.
METHOD: All participants with schizophrenia (n = 510) in Xinjin, Chengdu, China were identified in an epidemiological investigation of 123 572 people and followed up from 1994 to 2008.
RESULTS: The results showed that there were 30.6%, 25.0% and 20.4% of patients who received no antipsychotic medication in 1994, 2004 and 2008 respectively. Compared with treated patients, those who were never treated in 2008 were significantly older, had significantly fewer family members, had higher rates of homelessness, death from other causes, being unmarried, living alone, being without a caregiver and poor family attitudes. Partial and complete remission in treated patients (57.3%) was significantly higher than that in the never-treated group (29.8%). Predictors of being in the never-treated group in 2008 encompassed baseline never-treated status, being without a caregiver and poor mental health status in 1994.
CONCLUSIONS: Many patients with schizophrenia still do not receive antipsychotic medication in rural areas of China. The 14-year follow-up showed that outcomes for the untreated group were worse. Community-based mental healthcare, health insurance and family intervention are crucial for earlier diagnosis, treatment and rehabilitation in the community. © The Royal College of Psychiatrists 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26382951      PMCID: PMC4664855          DOI: 10.1192/bjp.bp.114.157685

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  41 in total

1.  Treatment delay and response rate in first episode psychosis.

Authors:  A Wunderink; F J Nienhuis; S Sytema; D Wiersma
Journal:  Acta Psychiatr Scand       Date:  2006-04       Impact factor: 6.392

2.  Psychopathology in never-treated schizophrenia.

Authors:  Srinivasan N Tirupati; Ramachandran Padmavati; Rangaswamy Thara; Robin G McCreadie
Journal:  Compr Psychiatry       Date:  2006 Jan-Feb       Impact factor: 3.735

3.  Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.

Authors:  Robin Emsley; Jonathan Rabinowitz; Rossella Medori
Journal:  Schizophr Res       Date:  2006-11-07       Impact factor: 4.939

4.  Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.

Authors:  M Lambert; D Naber; A Schacht; T Wagner; H-P Hundemer; A Karow; C G Huber; D Suarez; J M Haro; D Novick; R W Dittmann; B G Schimmelmann
Journal:  Acta Psychiatr Scand       Date:  2008-09       Impact factor: 6.392

5.  Mortality in people with schizophrenia in rural China: 10-year cohort study.

Authors:  Mao-Sheng Ran; Eric Yu-Hai Chen; Yeates Conwell; Cecilia Lai-Wan Chan; Paul S F Yip; Meng-Ze Xiang; Eric D Caine
Journal:  Br J Psychiatry       Date:  2007-03       Impact factor: 9.319

6.  Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

Authors:  Diego Novick; Josep Maria Haro; David Suarez; Martin Lambert; Jean-Pierre Lépine; Dieter Naber
Journal:  Psychopharmacology (Berl)       Date:  2007-02-20       Impact factor: 4.530

7.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

8.  Clinical course and outcome of schizophrenia in a predominantly treatment-naive cohort in rural Ethiopia.

Authors:  Atalay Alem; Derege Kebede; Abebaw Fekadu; Teshome Shibre; Daniel Fekadu; Teferra Beyero; Girmay Medhin; Alemayehu Negash; Gunnar Kullgren
Journal:  Schizophr Bull       Date:  2008-04-29       Impact factor: 9.306

9.  Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications.

Authors:  Alan S Bellack
Journal:  Schizophr Bull       Date:  2006-02-03       Impact factor: 9.306

Review 10.  Questioning an axiom: better prognosis for schizophrenia in the developing world?

Authors:  Alex Cohen; Vikram Patel; R Thara; Oye Gureje
Journal:  Schizophr Bull       Date:  2007-09-28       Impact factor: 9.306

View more
  17 in total

1.  What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Authors:  Christoph U Correll; Jose M Rubio; John M Kane
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

2.  Long-term antipsychotic treatment of schizophrenia: does it help or hurt over a 20-year period?

Authors:  Martin Harrow; Thomas H Jobe
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

Review 3.  Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective.

Authors:  Stephen M Lawrie
Journal:  Ther Adv Psychopharmacol       Date:  2018-06-15

4.  Cannabis Use and Associated Harms among Schizophrenia Patients in a Nigerian Clinical Setting: A Case-Control Study.

Authors:  Victor Lasebikan; Olaolu O Aremu
Journal:  Front Psychiatry       Date:  2016-08-03       Impact factor: 4.157

5.  Awareness, utilization and influencing factors of social supports for main informal caregivers of schizophrenia patients: a cross-sectional study in primary care settings in Beijing, China.

Authors:  Meirong Wang; Guanghui Jin; Yun Wei; Feiyue Wang; Zhaolu Pan; Lifen Chen; Xiaoqin Lu
Journal:  BMC Fam Pract       Date:  2020-09-17       Impact factor: 2.497

6.  Changes in treatment status of patients with severe mental illness in rural China, 1994-2015.

Authors:  Mao-Sheng Ran; Xue Weng; Yu-Jun Liu; Tian-Ming Zhang; Yue-Hui Yu; Man-Man Peng; Wei Luo; Shi-Hui Hu; Xin Yang; Bo Liu; Tin Zhang; Graham Thornicroft; Cecilia Lai-Wan Chan; Meng-Ze Xiang
Journal:  BJPsych Open       Date:  2019-03

7.  Homelessness and severe mental illness in low- and middle-income countries: scoping review.

Authors:  Caroline Smartt; Martin Prince; Souci Frissa; Julian Eaton; Abebaw Fekadu; Charlotte Hanlon
Journal:  BJPsych Open       Date:  2019-06-24

8.  Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder.

Authors:  Christina J Hsieh; Douglass Godwin; Daniel Mamah
Journal:  Front Psychiatry       Date:  2016-08-26       Impact factor: 4.157

9.  Development of Chinese mental health first aid guidelines for psychosis: a Delphi expert consensus study.

Authors:  Wenjing Li; Anthony F Jorm; Yan Wang; Shurong Lu; Yanling He; Nicola Reavley
Journal:  BMC Psychiatry       Date:  2020-09-10       Impact factor: 3.630

10.  "It means so much for me to have a choice": a qualitative study providing first-person perspectives on medication-free treatment in mental health care.

Authors:  Christine H Oedegaard; Larry Davidson; Brynjulf Stige; Marius Veseth; Anne Blindheim; Linda Garvik; Jan-Magne Sørensen; Øystein Søraa; Ingunn Marie Stadskleiv Engebretsen
Journal:  BMC Psychiatry       Date:  2020-08-08       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.